InsidersTradesSigma
Genovis AB Stock: price and insider trades · Finland · FIN-FSA
Track the Genovis AB stock price and the full management transaction log of the company, a listed issuer based in Finland. Shares are listed on FI FI, under the oversight of FIN-FSA. Operating in the Healthcare & Pharma sector, Genovis AB has published 7 reports. Market capitalisation: €1.3bn. The latest transaction was disclosed on 15 May 2026 (Purchase). Among the most active insiders: Steven Jordan. The full history is free.
7
Insider Decl.
0
Thresholds
€61,379
5 ops.
Buy Volume
€1m
2 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Genovis AB Strong Buy (bullish), based on 3 analysts. Average price target: SEK 33.00.
32Σ signal
Fundamental score
Ranked 12,169 of 26,120 companies
53.8
score / 100
Value34
Quality74
FCF yld1.6%
Earn yld1.9%
EV/EBITDA31.0x
ROE9.5%
Gross mgn90%
Net mgn18%
Debt/EBITDA1.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 15 May 2026
Declarations7 total
4,146 shares@ €1.670.0005% mcap50.0% of flowAktieFI:csv-3038ed09a69538b751f4
Ideal exit: 9 Feb 2027 (T+270)
4,146 shares@ SEK 18.4490.0005% mcap100.0% of flowAktieFI:A003Y639-1
Ideal exit: 9 Feb 2027 (T+270)
2,470 shares@ €1.58930.0003% mcap100.0% of flowAktieFI:A003W421-1
Ideal exit: 21 Nov 2026 (T+270)
13,000 shares@ €1.63640.0016% mcap48.8% of flowAktieFI:A003W055-1
Ideal exit: 13 Nov 2026 (T+270)
255,653 shares@ €2.34420.044% mcap52.5% of flowAktieFI:A003O854-1
235,000 shares@ €2.30380.040% mcap47.5% of flowAktieFI:A003M263-1
10,418 shares@ €2.14360.0016% mcap51.2% of flowAktieFI:A003M248-1
Ideal exit: 1 Dec 2025 (T+270)
7 of 7 declarations
About Genovis AB
Genovis AB is a company focused on developing technologies for biopharmaceuticals, particularly tools for antibody modification. It is listed on the XSTO exchange.
